FCG Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

FCG Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-34,000	Closed	-$136K	–	180
2019 Q4	$136K	Hold	34,000	–	–	0.04%	162
2019 Q3	$167K	Hold	34,000	–	–	0.05%	156
2019 Q2	$207K	Hold	34,000	–	–	0.07%	151
2019 Q1	$198K	Hold	34,000	–	–	0.07%	145
2018 Q4	$458K	Hold	34,000	–	–	0.17%	77
2018 Q3	$660K	Hold	34,000	–	–	0.23%	58
2018 Q2	$869K	Buy	+34,000	New	+$793K	0.31%	46
2017 Q3	–	Sell	-34,000	Closed	-$503K	–	144
2017 Q2	$503K	Buy	+34,000	New	+$567K	0.17%	72
2017 Q1	–	Sell	-34,000	Closed	-$428K	–	126
2016 Q4	$428K	Buy	+34,000	New	+$633K	0.19%	61

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

FCG Advisors's DPLO Position: Q1 2020 in Review

FCG Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 34,000 shares — an estimated $136K sold.

FCG Advisors first reported a position in DPLO in Q4 2016 and held it in 9 quarters. The position peaked at $869K in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

FCG Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
FCG Advisors sold 34,000 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $136K.
FCG Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 9 quarters.
FCG Advisors's DIPLOMAT PHARMACY, INC. position peaked at $869K in Q2 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on FCG Advisors's 13F filing for Q1 2020, filed 12 May 2020.